TELA Bio Investor Relations Material

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company's primary product is TELA Biosurgery System, which enables surgeons to perform minimally invasive soft-tissue surgeries, such as fat grafts for breast augmentation, facial rejuvenation, and body contouring. TELA Biomedical Systems is dedicated to enabling surgeons to recreate patients' own tissue regionally or locally.